Lansforsakringar Fondforvaltning’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.25M Sell
27,170
-800
-3% -$217K 0.04% 332
2025
Q4
$7.02M Buy
27,970
+225
+0.8% +$59.8K 0.03% 348
2025
Q3
$7.96M Buy
27,745
+3,395
+14% +$910K 0.04% 318
2025
Q2
$6.39M Sell
24,350
-2,164
-8% -$527K 0.04% 350
2025
Q1
$6.17M Sell
26,514
-389
-1% -$94.4K 0.04% 351
2024
Q4
$6.17M Buy
+26,903
New +$6.17M 0.03% 362

Other funds holding LH

Lansforsakringar Fondforvaltning's LH Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Labcorp (LH) stake by 2.9% in Q1 2026, selling an estimated $217K and leaving 27,170 shares worth $7.25M. The position accounts for 0.04% of the portfolio, ranked #332.

Lansforsakringar Fondforvaltning first reported a position in LH in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.96M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 27,170 shares of Labcorp worth $7.25M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 800 Labcorp shares in Q1 2026, an estimated $217K.
  • Labcorp made up 0.04% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #332 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Labcorp in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Labcorp position peaked at $7.96M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.